UK specialty chemicals company Croda has signed partnership agreements with US companies Amyris and Botanical Solutions Inc (BSI) to source sustainable vaccine adjuvants...
US biotech Amyris has formed a 50:50 joint venture with compatriot clinical-stage immunotherapy firm ImmunityBio to accelerate the commercialization of a next-generation...
Synthetic biotech company Amyris said it has successfully scaled up commercial production of cannabigerol (CBG) through leveraging its industrial fermentation process...
24.07.2019
- Leon, Spain-based ADL Bionatur Solutions and Amyris of Emeryville, California, USA, have extended an existing production agreement that foresees ADL producing up to five fermented...
17.04.2018
- For the global specialty chemicals sector, the past two years have been among the most exciting of the young millennium. Many mergers and acquisitions were in the spotlight in 2017...
23.11.2017
- DSM is buying Amyris Brasil from its long-term partner Amyris for $58 million. The acquisition includes the Brotas 1 production plant in Sao Paulo, Brazil, and intellectual...
12.10.2017
- As part of their long-term cooperation, DSM and US industrial bioscience company Amyris have entered into another agreement to develop and produce a new class of human nutrition...
10.05.2017
- DSM has agreed to make an initial investment of $25 million in US industrial bioscience company Amyris, giving it an equity stake of about 12%. The Dutch group may then invest a...
